Frontlight ResearchEarly access
Taking people in United KingdomNo phase
Real-world results of Vercise deep brain stimulation for dystonia
Follows people with dystonia treated with Vercise deep brain stimulation in routine care.
Key facts
- Who runs it
- Boston Scientific Corporation
- Where
- Bristol, Glasgow, London, and Newcastle upon Tyne, United KingdomSee the 4 sitesAlso in 11 other countries, 32 sites
- Trial code
- Registry title
- Vercise™ DBS Dystonia Prospective Study
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 7 Mar 2016
- Expected to end
- Dec 2030
- Type of study
- Observational
- Treatments tested
- Deep Brain Stimulation (DBS)
- Record updated
- 13 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with dystonia who get the Vercise deep brain stimulation (DBS) system. It collects real-world results.
- Age
- 7 years and older. People younger than 18 need consent from a parent or guardian.
- Sex
- All sexes can join.
- Disease stage
- Dystonia that meets the conditions in the local Vercise System Directions for Use.
Main reasons for not taking part
- Any reason listed in the local Vercise System Directions for Use why the device must not be used
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia
- IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent
Who cannot take part
- EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use
Where in United Kingdom
Also in 11 other countries, 32 sites
- Southmead Hospital BristolBristol, United KingdomContact: Stephanie DelvauxNo longer taking part
- Queen Elizabeth University HospitalGlasgow, United KingdomContact: Stephanie DelvauxNo longer taking part
- Charing Cross HospitalLondon, United KingdomContact: Boston Scientific Clinical ResearchTaking people
- Royal Victoria InfirmaryNewcastle upon Tyne, United KingdomContact: Boston Scientific Clinical Research ManagerTaking people
About the trial
What the trial wants to find out
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Treatments tested
- Deep Brain Stimulation (DBS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia
- Plain-language title
- Real-world results of Vercise deep brain stimulation for dystoniaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 13 October 2026